FOX 4: Missouri Man Finds New Hope With Innovative Heart Procedure at Saint Luke's
A Missouri resident is the the first patient in the country to participate in a pivotal trial to treat heart failure.
1 minuteThe first American to participate in a pivotal clinical trial aimed at treating heart failure received treatment right here in Kansas City at Saint Luke's Hospital.
In November, Kenneth Sondermeyer underwent the new procedure as a part of the RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) clinical trial.
FOX 4 talked with Kenneth and his cardiologist, Dr. Andrew Kao, medical director of cardiac transplantation at Saint Luke’s Mid America Heart Institute, about this minimally invasive new option that is changing the game for heart failure patients who have suffered heart attacks like Kenneth.
Relevant News
News
Health News You Can Use: Saint Luke’s Koontz Center for Advanced Breast Cancer’s 10th Anniversary
News
Health News You Can Use: Breast Cancer Awareness Month: High Risk Breast Clinic
News
KSHB: Pope Leo XIV Diagnosed with Lung Cancer: What To Know
News
KSHB: Innovative Treatment Combination for Metastatic Breast Cancer Takes Patient From Near Death to Life
News
Jennifer Clark Named Hedrick Medical Center Employee of Quarter–Third Quarter 2026
News